Subscribe to The Biotech Times
Four briefings, one industry. Pick the ones that fit how you work.
About The Biotech Times
The Biotech Times is the news, analysis and intelligence publication for the professionals shaping the future of biotechnology — from genomics and drug discovery to medtech, cell therapy and synthetic biology.
We cover the science, the capital, the policy, and the people behind the companies redrawing the industry. Our readers are senior operators, investors, regulators and researchers in the UK, Europe, the Gulf, the US and Asia-Pacific.
The Biotech Times Editorial Team
Biography
The Biotech Times editorial team covers the companies, capital, and policy shaping the biotechnology industry. Tips and correspondence: editorial@thebiotechtimes.com.
Organisation
The Biotech Times
Photo
Role / Job title
Editorial Team
Mark Walker
Biography
Mark Walker is CEO of Disrupts Media and founding editor of The Biotech Times. He writes on biotech investment, regulation, and the economics of life-science innovation.
LinkedIn profile
Organisation
Disrupts Media
Photo
Role / Job title
CEO
Genomics
Inside the UK's £650m bet on genomic medicine
The UK government has quietly positioned itself at the front of a race few of its peers are even running.
Cell Therapy
Cell therapy's second act: why Boston is still winning
When the FDA approved the first CAR-T therapy for leukaemia in 2017, the assumption across the industry was that the blood cancer playbook would translate quickly into solid tumours. It did not.
AgriTech
UAE's agritech push: food security as industrial policy
The UAE imports roughly 85 per cent of its food. For a country that has made state-capacity industrial policy a signature of its modernisation, that number is not a fact to be accepted — it is a problem to be solved with capital and technology.